BSW Wealth Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,626
| Closed | -$247K | – | 328 |
|
|
2024
Q4 | $247K | Sell |
18,626
-3,464
| -16% | -$45.9K | 0.04% | 267 |
|
|
2024
Q3 | $314K | Buy |
22,090
+2,992
| +16% | +$42.5K | 0.05% | 217 |
|
|
2024
Q2 | $247K | Sell |
19,098
-3,332
| -15% | -$43.1K | 0.04% | 245 |
|
|
2024
Q1 | $312K | Buy |
22,430
+5,155
| +30% | +$71.6K | 0.05% | 217 |
|
|
2023
Q4 | $247K | Buy |
17,275
+311
| +2% | +$4.44K | 0.05% | 232 |
|
|
2023
Q3 | $262K | Sell |
16,964
-12,184
| -42% | -$188K | 0.06% | 197 |
|
|
2023
Q2 | $458K | Sell |
29,148
-548
| -2% | -$8.61K | 0.1% | 119 |
|
|
2023
Q1 | $489K | Sell |
29,696
-12,219
| -29% | -$201K | 0.1% | 137 |
|
|
2022
Q4 | $654K | Buy |
41,915
+22,259
| +113% | +$347K | 0.14% | 108 |
|
|
2022
Q3 | $255K | Sell |
19,656
-14,665
| -43% | -$190K | 0.06% | 217 |
|
|
2022
Q2 | $482K | Buy |
34,321
+5,179
| +18% | +$72.7K | 0.12% | 126 |
|
|
2022
Q1 | $417K | Buy |
29,142
+10,496
| +56% | +$150K | 0.11% | 150 |
|
|
2021
Q4 | $254K | Buy |
18,646
+2,605
| +16% | +$35.5K | 0.06% | 217 |
|
|
2021
Q3 | $263K | Buy |
16,041
+2,337
| +17% | +$38.3K | 0.07% | 207 |
|
|
2021
Q2 | $231K | Buy |
13,704
+1,294
| +10% | +$21.8K | 0.06% | 213 |
|
|
2021
Q1 | $227K | Buy |
+12,410
| New | +$227K | 0.07% | 191 |
|